(HBIO) Harvard Bioscience - Performance -89.4% in 12m
Compare HBIO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-77.45%
#45 in Group
Rel. Strength
1.41%
#7920 in Universe
Total Return 12m
-89.41%
#48 in Group
Total Return 5y
-85.99%
#43 in Group
P/E -
(?) Percentile in Group
P/E Forward 14.9
28th Percentile in Group
PEG 2.89
75th Percentile in Group
FCF Yield -2.49%
33th Percentile in Group
12m Total Return: HBIO (-89.4%) vs XLV (0.3%)
5y Drawdown (Underwater) Chart
Top Performers in Life Sciences Tools & Services
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| A NYSE Agilent Technologies |
-11.6% | -21.5% | 44.2% | 23.5 | 18.4 | 1.68 | 58.4% | 7.8% |
| RVTY NYSE Revvity |
-12.1% | -7.4% | 7.42% | 39 | 18.2 | 0.64 | -63.9% | -30.6% |
| TECH NASDAQ Bio-Techne |
-16.2% | -19.5% | -1.48% | 51.8 | 22.6 | 1.07 | -31.9% | -5.85% |
| SHC NASDAQ Sotera Health |
-6.5% | -1.46% | -55.6% | 65.6 | 20.2 | 1.68 | -43.6% | - |
Performance Comparison: HBIO vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for HBIO
| Total Return (including Dividends) | HBIO | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -36.35% | -4.97% | -4.31% |
| 3 Months | -79.06% | -6.08% | -7.85% |
| 12 Months | -89.41% | 0.26% | 10.76% |
| 5 Years | -85.99% | 47.01% | 106.31% |
| Trend Score (consistency of price movement) | HBIO | XLV | S&P 500 |
| 1 Month | -71.2% | -54.4% | -35.6% |
| 3 Months | -98.6% | -66.1% | -89.7% |
| 12 Months | -96.9% | -12% | 58.3% |
| 5 Years | -41.9% | 90% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #48 | -33.0% | -33.5% |
| 3 Month | #50 | -77.7% | -77.3% |
| 12 Month | #48 | -89.4% | -90.4% |
| 5 Years | #43 | -90.5% | -93.2% |
FAQs
Does HBIO Harvard Bioscience outperforms the market?
No,
over the last 12 months HBIO made -89.41%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.26%.
Over the last 3 months HBIO made -79.06%, while XLV made -6.08%.
Over the last 3 months HBIO made -79.06%, while XLV made -6.08%.
Performance Comparison HBIO vs Indeces and Sectors
HBIO vs. Indices HBIO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.66% | -32.0% | -79.5% | -100% |
| US NASDAQ 100 | QQQ | -5.62% | -32.1% | -79.5% | -101% |
| US Dow Jones Industrial 30 | DIA | -1.59% | -30.6% | -79.7% | -96.4% |
| German DAX 40 | DAX | -1.0% | -32.5% | -97.9% | -113% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.87% | -32.9% | -78.0% | -98.0% |
| Hongkong Hang Seng | HSI | -1.39% | -33.5% | -81.3% | -103% |
| India NIFTY 50 | INDA | 3.77% | -37.9% | -81.1% | -91.2% |
| Brasil Bovespa | EWZ | -3.41% | -38.3% | -84.0% | -83.9% |
HBIO vs. Sectors HBIO is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.52% | -30.8% | -88.2% | -112% |
| Consumer Discretionary | XLY | -6.01% | -32.3% | -82.6% | -104% |
| Consumer Staples | XLP | 3.80% | -39.1% | -84.8% | -98.9% |
| Energy | XLE | -0.31% | -24.7% | -77.0% | -77.5% |
| Financial | XLF | -1.70% | -31.6% | -87.6% | -109% |
| Health Care | XLV | -0.64% | -31.4% | -77.4% | -89.7% |
| Industrial | XLI | -1.83% | -32.3% | -79.8% | -96.3% |
| Materials | XLB | -0.41% | -31.8% | -72.6% | -84.1% |
| Real Estate | XLRE | 1.17% | -34.4% | -77.3% | -105% |
| Technology | XLK | -7.47% | -31.8% | -74.6% | -95.7% |
| Utilities | XLU | 0.49% | -38.0% | -82.6% | -110% |
| Aerospace & Defense | XAR | -3.22% | -36.1% | -90.7% | -116% |
| Biotech | XBI | -2.79% | -28.5% | -66.4% | -87.2% |
| Homebuilder | XHB | -1.91% | -30.3% | -64.5% | -81.4% |
| Retail | XRT | -0.87% | -33.4% | -75.3% | -85.8% |